Evidence map›Paper›PMID 25340560›Full record

ArticlePLoS genetics2014

Recovery from an acute infection in C. elegans requires the GATA transcription factor ELT-2.

Brian Head, Alejandro Aballay

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Ubiquitin-related processes and innate immunity in C. elegans.Cellular and molecular life sciences : CMLS · 2021
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Brian HeadDepartment of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina, United States of America.
Alejandro AballayDepartment of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina, United States of America.
Duke Medical Center · US

Funding

Genetic analysis of innate immunity using C. elegansR01GM070977 · NIGMS · DUKE UNIVERSITY · PI ABALLAY, ALEJANDRO · 2004 to 2016
$4.2M
Role of CED-1 in the Systemic Response to Pathogen Infection in C. elegansF32GM103122 · NIGMS · DUKE UNIVERSITY · PI HEAD, BRIAN · 2013 to 2014
$107k
NIGMS NIH HHS F32 GM103122NIGMS NIH HHS GM0709077NIGMS NIH HHS GM103122NIGMS NIH HHS R01 GM070977
6 · The paper itself

Abstract

The mechanisms involved in the recognition of microbial pathogens and activation of the immune system have been extensively studied. However, the mechanisms involved in the recovery phase of an infection are incompletely characterized at both the cellular and physiological levels. Here, we establish a Caenorhabditis elegans-Salmonella enterica model of acute infection and antibiotic treatment for studying biological changes during the resolution phase of an infection. Using whole genome expression profiles of acutely infected animals, we found that genes that are markers of innate immunity are down-regulated upon recovery, while genes involved in xenobiotic detoxification, redox regulation, and cellular homeostasis are up-regulated. In silico analyses demonstrated that genes altered during recovery from infection were transcriptionally regulated by conserved transcription factors, including GATA/ELT-2, FOXO/DAF-16, and Nrf/SKN-1. Finally, we found that recovery from an acute bacterial infection is dependent on ELT-2 activity.

Indexed as

AnimalsCaenorhabditis elegansCaenorhabditis elegans ProteinsComputer SimulationDisease Models, AnimalGATA Transcription FactorsImmunity, InnateInactivation, MetabolicInfectionsSalmonella entericaTranscriptomeWound HealingCaenorhabditis elegans ProteinsELT-2 protein, C elegansGATA Transcription Factors

Identifiers

PMID25340560
PMCPMC4207467
OpenAlexW2152320888

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.